Abbott Laboratories CEO buys $45.5M in company’s stock

Abbott Park, Ill.-based Abbott Laboratories CEO Miles White has purchased another 1.28 million shares — worth $45.5 million — in his company’s stock, according to Crain’s Chicago Business.

Advertisement

In April, Abbott said it would acquire St. Paul, Minn.-based St. Jude Medical. Meanwhile, Abbott is also working to acquire Waltham, Mass.-based Alere. Since Abbott said it may have to issue more equity to assist in funding for the deals, investors have started to worry.

But Mr. White’s most recent purchase is, perhaps, an attempt to soothe anxious investors. Mr. White now owns 2.74 million shares of Abbott stock, making him one of Abbott’s top 100 shareholders, according to Bloomberg.

More articles on finance:
6 healthcare CFOs in the headlines
13 recent hospital outlook and credit rating actions
Investigators link Mosaic’s aggressive collection methods to understaffing issues

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Reconsider What’s Possible: Enterprise RCM and the Pro-Fee Practice

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Garett Kreitz, Med-MetrixJohn Stefanowicz, Med-Metrix

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.